Aeterna Zentaris: Q4 Earnings Snapshot
By AP News
Published - Mar 27, 2024, 08:39 AM ET
Last Updated - Mar 27, 2024, 08:39 AM EDT
TORONTO (AP) — TORONTO (AP) — Aeterna Zentaris Inc. (AEZS) on Wednesday reported a loss of $5.6 million in its fourth quarter.
On a per-share basis, the Toronto-based company said it had a loss of $1.16.
The drug developer posted revenue of $121,000 in the period.
For the year, the company reported that its loss narrowed to $16.6 million, or $3.41 per share. Revenue was reported as $4.5 million.
